Japan Orders 50 Million Coronavirus Vaccine Doses

Massachusetts based Moderna, Inc. announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co., Ltd. have agreed to purchase and distribute 50 million doses of mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support Japan’s aim of providing vaccines to the Japanese public as soon as possible.

Takeda, with the support of the MHLW, the Japan Agency for Medical Research and Development, and Moderna, is responsible for all import, local regulatory, development, and distribution activities in Japan to ensure timely access starting during the first half of 2021.